Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats. (Q46017020)

18 December 2017

title

Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats. (English)

1 reference

18 December 2017

author name string

Nurith Amitai

series ordinal

1

1 reference

18 December 2017

Svetlana Semenova

series ordinal

2

1 reference

18 December 2017

Athina Markou

series ordinal

3

1 reference

18 December 2017

publication date

12 May 2007

1 reference

18 December 2017

number of pages

17

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

18 December 2017

volume

193

1 reference

18 December 2017

issue

4

1 reference

18 December 2017

page(s)

521-537

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-007-0808-x

exact match

0 references

cites work

Phencyclidine-induced psychosis

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0808-X

Gating and habituation of the startle reflex in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0808-X

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0808-X

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0808-X

Information processing and attentional functioning in the developmental course of schizophrenic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0808-X

Use of methods from chaos theory to quantify a fundamental dysfunction in the behavioral organization of schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0808-X

The cognitive efficacy of atypical antipsychotics in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0808-X

Differential effects of sigma and phencyclidine receptor ligands on learning

21 January 2018

1 reference

12 December 2020

Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment

1 reference

12 December 2020

Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat.

1 reference

12 December 2020

3-((+-)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) and phencyclidine produce a deficit of passive avoidance retention in rats.

1 reference

12 December 2020

The pharmacological characterization of attentional processes using a two-lever choice reaction time task in rats

1 reference

12 December 2020

Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine

1 reference

12 December 2020

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

1 reference

12 December 2020

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia

1 reference

12 December 2020

Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.

1 reference

12 December 2020

Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia.

1 reference

12 December 2020

Phencyclidine and behavior: II. Active avoidance learning and radial arm maze performance.

1 reference

12 December 2020

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol

1 reference

12 December 2020

Performance of schizophrenic patients on putative neuropsychological tests of frontal lobe function.

1 reference

12 December 2020

Acute behavioral effects of phencyclidine on rhesus monkey performance in an operant test battery.

1 reference

12 December 2020

Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.

1 reference

12 December 2020

The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry

1 reference

12 December 2020

Learning impairment in rats by N-methyl-D-aspartate receptor antagonists.

1 reference

12 December 2020

Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine

1 reference

12 December 2020

Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal.

1 reference

12 December 2020

Treatment of schizophrenia

1 reference

12 December 2020

Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia

1 reference

12 December 2020

Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition

1 reference

12 December 2020

1 reference

12 December 2020

Within-session repeated acquisition behavior in rats as a potential model of executive function

1 reference

12 December 2020

Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU(2/3) receptor agonist LY379268.

1 reference

12 December 2020

A simple procedure for assessing ataxia in rats: effects of phencyclidine

1 reference

12 December 2020

The involvement of sigma receptors in the choice reaction performance deficits induced by phencyclidine

1 reference

12 December 2020

Cognitive inflexibility and pre-frontal dysfunction in schizophrenia and mania

1 reference

12 December 2020

Performance of male C57BL/6J mice and Wistar rats in the water maze following various schedules of phencyclidine treatment

1 reference

12 December 2020

Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory

1 reference

12 December 2020

Studies on the involvement of the dopaminergic system in the 5-HT2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task

1 reference

12 December 2020

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants

1 reference

12 December 2020

Both competitive and non-competitive antagonists of N-methyl-D-aspartic acid disrupt brightness discrimination in rats.

1 reference

12 December 2020

Phencyclidine (PCP): some human studies

1 reference

12 December 2020

Disruption of brightness discrimination in a shock avoidance task by phencyclidine and its antagonism in rats.

1 reference

12 December 2020

Cognitive impairment in schizophrenia is the core of the disorder.

1 reference

12 December 2020

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

1 reference

12 December 2020

A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats

1 reference

12 December 2020

Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment

1 reference

12 December 2020

Spatial signal detection in rats is differentially disrupted by delta-9-tetrahydrocannabinol, scopolamine, and MK-801.

1 reference

12 December 2020

Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.

1 reference

12 December 2020

Selective memory impairment by phencyclidine in rats.

1 reference

12 December 2020

Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat.

1 reference

12 December 2020

Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives

1 reference

12 December 2020

The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis

1 reference

12 December 2020

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

1 reference

12 December 2020

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

1 reference

12 December 2020

The components of executive functioning in a cohort of patients with chronic schizophrenia: a multiple single-case study design.

1 reference

12 December 2020

Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats

1 reference

12 December 2020

NMDA antagonists disrupt timing behaviour in rats

1 reference

12 December 2020

Observations on the psychotomimetic effects of Sernyl.

1 reference

12 December 2020

Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions

1 reference

12 December 2020

The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism

1 reference

12 December 2020

The prevalence and stability of an executive processing deficit, response inhibition, in people with chronic schizophrenia.

1 reference

12 December 2020

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

1 reference

12 December 2020

Chronic nicotine interactions with clozapine and risperidone and attentional function in rats

1 reference

12 December 2020

Acts of control in schizophrenia: dissociating the components of inhibition.

1 reference

12 December 2020

Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats

1 reference

12 December 2020

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

1 reference

12 December 2020

Object retrieval/detour deficits in monkeys produced by prior subchronic phencyclidine administration: evidence for cognitive impulsivity.

1 reference

12 December 2020

Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

1 reference

12 December 2020

Combinations of clozapine and phencyclidine: effects on drug discrimination and behavioral inhibition in rats.

1 reference

12 December 2020

PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats

1 reference

12 December 2020

Executive control is disturbed in schizophrenia: evidence from event-related potentials in a Go/NoGo task

1 reference

12 December 2020

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Cognitive function in schizophrenia--do neuroleptics make a difference?

1 reference

12 December 2020

Phencyclidine intoxication: assessment of possible antidotes

1 reference

12 December 2020

Study of a new schizophrenomimetic drug; sernyl.

1 reference

12 December 2020

Rule shift under long-term PCP challenge in rats

1 reference

12 December 2020

The role of cognition in vocational functioning in schizophrenia.

1 reference

12 December 2020

Nicotinic-glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats

1 reference

12 December 2020

Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia

1 reference

12 December 2020

Subchronic phencyclidine treatment impairs performance of C57BL/6 mice in the attentional set-shifting task

1 reference

12 December 2020

Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats

1 reference

12 December 2020

Effects of drugs of abuse and cholinergic agents on delayed matching-to-sample responding in the squirrel monkey.

1 reference

12 December 2020

Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats

1 reference

12 December 2020

Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task

1 reference

12 December 2020

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.

1 reference

12 December 2020

Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats

1 reference

12 December 2020

Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats.

1 reference

12 December 2020

Schizophrenia and cognitive function

1 reference

12 December 2020

Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity

1 reference

12 December 2020

Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character

1 reference

12 December 2020

Phencyclidine-induced behavioral sensitization

1 reference

12 December 2020

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

1 reference

12 December 2020

Nicotine-antipsychotic drug interactions and attentional performance in female rats

1 reference

12 December 2020

Cognitive functioning and symptomatology in chronic schizophrenia

1 reference

12 December 2020

10.1007/S00213-007-0808-X

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

17497138

1 reference

18 December 2017